IP Verse

Mesenchymal Stem Cells And Uses Therefor - EP2824174

The patent EP2824174 was granted to Mesoblast on Nov 28, 2018. The application was originally filed on Mar 15, 2005 under application number EP14172800A. The patent is currently recorded with a legal status of "Revoked".

EP2824174

MESOBLAST
Application Number
EP14172800A
Filing Date
Mar 15, 2005
Status
Revoked
Aug 19, 2022
Grant Date
Nov 28, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

FRIEDRICHAug 27, 2019DORRIESADMISSIBLE
CHIESI FARMACEUTICIAug 7, 2019HANSENADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS5486359
DESCRIPTIONUS6355239
OPPOSITIONUS2003130228
OPPOSITIONUS5382514
OPPOSITIONWO03059272
OPPOSITIONWO2005093044
OPPOSITIONWO9630031
SEARCHEP1279738
SEARCHJP4554940B
SEARCHJP4554940K
SEARCHUS2002037278
SEARCHWO03059272

Non-Patent Literature (NPL) Citations (69) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BALLAS ET AL., J. CELL. BIACHEM. SUPPL., (2002), vol. 38, page 20-
DESCRIPTION- BARTHOLOMEW ET AL., EXP. HEMATOL., (2002), vol. 30, page 42-
DESCRIPTION- CHOPP ET AL., NEUROREPORT, (2000), vol. 11, page 3001-
DESCRIPTION- DEKOK ET AL., CLIN. ORAL IMPLANTS RES., (2003), vol. 14-
DESCRIPTION- DENICOLA ET AL., BLOOD, (2002), vol. 99, page 3838-
DESCRIPTION- DEVINE ET AL., CANCER J., (2001), vol. 7, page 576-
DESCRIPTION- DINICOLA, BLOOD, (2002), vol. 99, page 3838-
DESCRIPTION- DINICOLA ET AL., BLOOD, (2002), vol. 99, page 3838-
DESCRIPTION- DZLONEK ET AL., J. IMMUNOL., (2000), vol. 165, page 6037-
DESCRIPTION- EAVES ET AL., ANN. N.Y. ACAD. SCI., (2001), vol. 938, page 63-
DESCRIPTION- FAKUDA, ARTIF. ORGANS, (2001), vol. 25, page 187-
DESCRIPTION- HARRIS ET AL., TRENDS IMMUNOL., (2002), vol. 23, page 144-
DESCRIPTION- HAYNESWORTH ET AL., BONE, (1992), vol. 13, page 69-
DESCRIPTION- HAYNESWORTH ET AL., J. CELL. PHYSIOL., (1996), vol. 166, page 585-
DESCRIPTION- HOROWITZ ET AL., PROC. NAT. ACAD. SCI., (2002), vol. 99, page 8932-
DESCRIPTION- HORWITZ ET AL., BLOOD, (2001), vol. 97, page 1227-
DESCRIPTION- KINGSLEY ET AL., J. IMMUNOL., (2002), vol. 168, page 1080-
DESCRIPTION- KOC ET AL., J. CLIN. ONCOL., (2000), vol. 18, page 307-
DESCRIPTION- LE BLANC ET AL., EXP. HEMATOL., (2003), vol. 31, page 890-
DESCRIPTION- LEBLANC ET AL., EXP. HEMATOL., (2003), vol. 31, page 890-
DESCRIPTION- LEBLANC ET AL., SCAND J. IMMUNOL., (2003), vol. 57, page 11-
DESCRIPTION- LEBLANC ET AL., SCAND. J. LMMUNOL., (2003), vol. 57, page 11-
DESCRIPTION- MACKENZIE ET AL., BLOOD CELLS MOL. DIS., (2002), vol. 27-
DESCRIPTION- MAJUMDAR ET AL., HEMATOTHER. STEM CELL RES., (2000), vol. 9, page 841-
DESCRIPTION- MAJUMDAR ET AL., J. BLOMED. SCL., (2003), vol. 10, page 228-
DESCRIPTION- NOEL ET AL., CURR. OPIN. INVESTIG. DRUGS, (2002), vol. 3, page 1000-
DESCRIPTION- PEREIRA, PROC. NAT. ACAD. SCL., (1998), vol. 95, page 1142-
DESCRIPTION- PITTENGER ET AL., SCIENCE, (1999), vol. 284, page 143-
DESCRIPTION- POTIAN ET AL., J.IMMUNOL., (2003), vol. 171, page 3426-
DESCRIPTION- PROCKOP, SCIENCE, (1997), vol. 276, page 71-
DESCRIPTION- SANCHEZ-RAMOS ET AL., EXP. NEUROL., (2001), vol. 171, page 109-
DESCRIPTION- SCHWARTZ ET AL., HUM. GENE THER., (1999), vol. 10, page 2539-
DESCRIPTION- SHAKE ET AL., ANN. THORAC. SURG., (2002), vol. 73, page 1919-
DESCRIPTION- TOMA, CIRCULATION, (2002), vol. 105, page 93-
DESCRIPTION- TOMITA ET AL., CIRCULATION, (1999), vol. 100, page 247-
DESCRIPTION- TSE ET AL., TRANSPLANTATION, (2003), vol. 75, page 389-
DESCRIPTION- VASSLLLOU ET AL., CELL. IMMUNOL., (2003), vol. 223, page 120-
DESCRIPTION- WAGERS ET AL., GENE THERAPY, (2002), vol. 9, page 606-
DESCRIPTION- WAKITANI ET AL., MUSCLE NERVE, (1995), vol. 18, page 1417-
DESCRIPTION- WOODBURY ET AL., J. NEUROSCL. RES., (2002), vol. 69, page 908-
DESCRIPTION- WU ET AL., J. NEUROSCI. RES., (2003), vol. 72, page 393-
DESCRIPTION- WU ET AL., TRANSPLANTATION, (2003), vol. 75, page 679-
OPPOSITION- AI-KHALDI, A. et al., "Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo", Gene Therapy, (20030000), vol. 10, pages 621 - 629, XP007913740-
OPPOSITION- AL-KHALDI et al., "Abstracts 594: VEGF-Dependant Angiogenetic response Induced by Ex-Vivocultured Marrow Stromal cells", Abstracts From Sclentific Basic Mechanisms of Angiogenesis, (20010000), page 123, XP055628678-
OPPOSITION- AL-KHALDI et al., "Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo", Gene Ther., (20030100), vol. 10, pages 621 - 629, XP007913740-
OPPOSITION- Anonymous, "Definition of angiogenesis", Oxford Dictionary, (20180000), URL: https://en.oxforddictionaries.com/definition/angiogenesis, XP055628680-
OPPOSITION- CHEN, J. et al., "Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats", Circulation Research, (20030000), vol. 92, pages 692 - 699, XP002997919-
OPPOSITION- JORGENSEN, C. et al., "Mesenchymal stem cells and rheumatoid arthritis", Joint Bone Spine, (20030000), vol. 70, pages 483 - 485, XP009145230-
OPPOSITION- KINNAIRD et al., "Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanisms", Circ. Res., (20040122), vol. 94, no. 5, pages 678 - 685, XP002645527-
OPPOSITION- BARRY, F. P., "Biology and clinical applications of mesenchymal stem cells", Birth defects Res., (20030000), vol. 69, pages 250 - 256, XP002976497
OPPOSITION- TOMITA S. et al., "The Use of Bone Marrow Mesenchymal Stem Cells to Repair the Infarcted Heart", Cardiac Remodeling and Failure. Progress in Experimental Cardiology, Boston, USA, (20030100), vol. 5, pages 345 - 354, XP055628670
OPPOSITION- CEBE-SUAREZ et al., "The role of VEGF receptors in angiogenesis; complex partnerships", Cell . Mol. Life Sci., (20060300), vol. 63, no. 5, pages 601 - 615, XP019201039
OPPOSITION- NOWAK-SLIWINSKA et al., "Consensus guidelines for the use and interpretation of angiogenesis assays", Angiogenesis, (20180515), vol. 21, no. 3, pages 425 - 532, XP036546406
OPPOSITION- AL-KHALDI, A. et al., "Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model", Annals of Thoracic Surgery, (20030000), vol. 75, pages 204 - 209, XP055272023
OPPOSITION- DEANS, R. J. et al., "Mesenchymal stem cells: Biology and potential clinical uses", Exp. Hematol., (20000000), vol. 28, pages 875 - 884, XP002201188
OPPOSITION- LE BLANC, K., "Immunomodulatory effects of fetal and adult mesenchymal stem cells", Cytotherapy, (20030000), vol. 5, no. 6, pages 485 - 489, XP008075543
OPPOSITION- KAIGLER et al., "Role ofV ascular Endothelial GrowthFactorinB one Marrow Stromal Cell Modulation ofEndothelial Cells", Tissue Engin., (20030200), vol. 9, no. 1, pages 95 - 103, XP007913738
OPPOSITION- STATON et al., "A critical analysis of current in vitro and in vivo angiogenesis assays : Current in vitro and in vivo angiogenesis assays", Int. J. Exp. Path., (20090511), vol. 90, no. 3, pages 195 - 221, XP055453763
OPPOSITION- PITTENGER et al., "MULTILINEAGE POTENTIAL OF ADULT HUMAN MESENCHYMAL STEM CELLS", Science, (19990402), vol. 284, no. 5411, pages 143 - 147, XP000867221
OPPOSITION- LINDNER et al., "Mesenchymal Stem or Stromal Cells: Toward a Better Understanding of Their Biology?", Transfus. Med. Hemother., (20100000), vol. 37, no. 2, pages 75 - 83, XP055489860
OPPOSITION- KINNAIRD, T. et al., "Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms", Circulation, (20040000), vol. 109, pages 1543 - 1549, XP009075541
OPPOSITION- KINNAIRD, T. et al., "Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanisms", Circulation Research, (20040000), vol. 94, pages 687 - 685, XP055001132
OPPOSITION- KHOURI et al., "Flow in the Maior Branches of the Left Coronary Artery during Experimental Coronary Insufficiency in the Unanesthetized Dog", Circulation Research, (19680700), vol. 23, no. 1, pages 99 - 109, XP055628656
OPPOSITION- KRAMPERA, M. et al., "Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide", Blood, (20030000), vol. 101, pages 3722 - 3729, XP055496530
OPPOSITION- FERRARA N., "Vascular endothelial growth factor: basic science and clinical progress", Endocrine Reviews, (20040800), vol. 25, no. 4, pages 581 - 611, XP002493206
OPPOSITION- AUERBACH et al., "Angiogenesis assays: a critical overview", Clin. Chem., (20030100), vol. 49, no. 1, pages 32 - 40, XP002595434
OPPOSITION- CIMPEAN et al., "A brief history o f ang1ogenes1s assays", Int. J. Dev. Biol., (20110000), vol. 55, no. 4-5, pages 377 - 382, XP055628672
OPPOSITION- Katrina Mcnulty, Sam M. Janes, "Stem Cells and Pulmonary Fibrosis: Cause or Cure?", AMERICAN THORACIC SOCIETY. PROCEEDINGS, AMERICAN THORACIC SOCIETY, NEW YORK,, US, US, (20120715), vol. 9, no. 3, doi:10.1513/pats.201201-010AW, ISSN 1546-3222, pages 164 - 171, XP055628683
SEARCH- TANG Y L ET AL, "Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium", REGULATORY PEPTIDES, ELSEVIER SCIENCE BV, NL, (20040115), vol. 117, no. 1, doi:10.1016/J.REGPEP.2003.09.005, ISSN 0167-0115, pages 3 - 10, XP002333008 [X] 1-7,13-15 * whole document esp. abstract, pages 7-9, Figure 3 * [Y] 1-15

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents